01875 TOT BIOPHARM-B
- 1.800
- -0.060-3.23%
TOT BIOPHARM-B News
TOT BIOPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024
TOT BIOPHARM-B: DATE OF BOARD MEETING
TOT BIOPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
TOT BIOPHARM-B: POLL RESULTS OF THE ADJOURNED ANNUAL GENERAL MEETING HELD ON 26 JUNE 2024
TOT BIOPHARM-B: NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED SHAREHOLDERS
TOT BIOPHARM-B: NOTIFICATION LETTER AND REQUEST FORM FOR REGISTERED SHAREHOLDERS
TOT BIOPHARM-B: THIRD FORM OF PROXY
TOT BIOPHARM-B: FURTHER SUPPLEMENTAL NOTICE OF ADJOURNED ANNUAL GENERAL MEETING
TOT BIOPHARM-B: ADDITIONAL PROPOSAL FOR RE-ELECTION OF RETIRING DIRECTORANDFURTHER SUPPLEMENTAL NOTICE OF ADJOURNED ANNUAL GENERAL MEETING
TOT BIOPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
TOT BIOPHARM-B: NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED SHAREHOLDERS
TOT BIOPHARM-B: NOTIFICATION LETTER AND REQUEST FORM FOR REGISTERED SHAREHOLDERS
TOT BIOPHARM-B: SECOND FORM OF PROXY
TOT BIOPHARM-B: SUPPLEMENTAL NOTICE OF ANNUAL GENERAL MEETING
TOT BIOPHARM-B: PROPOSED ADOPTION OFTHE 2024 RESTRICTED SHARE AWARD SCHEMEANDSUPPLEMENTAL NOTICE OF ANNUAL GENERAL MEETING
TOT BIOPHARM-B: PROPOSED ADOPTION OF THE 2024 RESTRICTED SHARE AWARD SCHEME
TOT BIOPHARM-B: NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED SHAREHOLDERS
TOT BIOPHARM-B: NOTIFICATION LETTER AND REQUEST FORM FOR REGISTERED SHAREHOLDERS
TOT BIOPHARM-B: FORM OF PROXY
TOT BIOPHARM-B: NOTICE OF ANNUAL GENERAL MEETING
Analysis
Price Target
No Data
